Annual Report 2021

FINANCIAL HIGHLIGHTS 6 The United Laboratories International Holdings Limited Annual Report 2021 2021 2020 Increase RMB’000 RMB’000 % Revenue 9,703,438 8,772,488 10.6% EBITDA 1,883,735 1,678,072 12.3% Profit before taxation 1,202,647 882,334 36.3% Profit for the year attributable to owners of the Company 988,098 702,989 40.6% Earnings per share Basic RMB53.7 cents RMB39.81 cents 34.9% Diluted RMB53.7 cents RMB39.81 cents 34.9% 2021 1,833.7 2021 1,700.3 3,968.6 4,034.5 641.8 81.8 682.9 2017 2017 1,125.5 2018 1,788.4 2019 1,798.2 2017 2018 5.0 41.8 39.1 39.8 2018 0 200 400 800 1,000 60 50 40 30 20 10 0 2019 2020 1,678.1 2020 2,000 1,500 1,000 500 0 10,000 8,000 6,000 4,000 2,000 0 2019 2020 1,473.5 2,853.4 2,499.7 1,233.6 3,389.7 2,887.3 6,826.6 7,510.6 8,392.6 1,280.4 3,593.1 3,519.1 8,772.5 1,429.7 3,620.7 3,722.1 703.0 53.7 2017 2018 2019 2020 2021 2021 988.1 9,703.4 REVENUE (RMB million) PROFIT FORTHEYEAR ATTRIBUTABLE TO OWNERS OFTHE COMPANY (RMB million) EBITDA (RMB million) Intermediate products Bulk medicine Finished products BASIC EARNINGS PER SHARE (RMB cents)

RkJQdWJsaXNoZXIy NTk2Nzg=